Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer

Figure 2 Receiver operating characteristic curve of all lung cancer patients and ground-glass opacities patients. A: Area under the receiver operating characteristic curve (AUC) of total circulating tumor cells (CTCs) and CTCs with both markers (E&M-CTCs) for lung cancer diagnosis were 0.828 and 0.7648, respectively; B: AUCs of total CTCs and E&M-CTCs for ground-glass opacity (GGO) diagnosis were 0.7963 and 0.7504, respectively.